Tularik Inc. made a management change that it said would more reflect the preponderance of its research organization and the development of its gene regulation technology, naming Vice President of Research David Goeddel as president to replace James Gower, who resigned last week as president and CEO.
"Jim has a marketing background," said Goeddel, who co-founded the South